Emerging Trends to Reshape the Peripheral Neuropathy Market: Technological Advancements In Peripheral Neuropathy Screening Enhanced Market as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Peripheral Neuropathy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for peripheral neuropathy has seen significant growth recently. The market is expected to expand from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. The historic growth can be linked to factors such as the increasing number of chronic diseases like diabetes, enhanced awareness regarding the management of neuropathic pain, a rise in the global elderly population, development of the healthcare infrastructure, existence of specialized healthcare centers, government initiatives targeting improved neurological health services, and wider adoption of innovative treatment choices.

Peripheral Neuropathy Market Size Forecast: What's the Projected Valuation by 2029?
The market for peripheral neuropathy is projected to undergo rapid expansion in the forthcoming years. The market worth is anticipated to reach $7.52 billion in 2029 with a compound annual growth rate (CAGR) of 12.9%. The increased growth in the projected period can be attributed to persistent rise in chronic diseases, particularly diabetes and cancer, advancements in pharmacological treatments focused on neuropathic pain pathways, escalating investment in innovative treatment modalities research and development, incorporation of digital health solutions for remote monitoring and personalized management of neuropathic symptoms, amplified attention on patient-centered care models, and enhanced access to multidisciplinary healthcare services. Key trends expected during this forecast period include increased adoption of personalized treatments, rising use of wearable tech for real-time tracking symptoms and treatment responses, expansion of telemedicine services for remote consultations and follow-ups, development of targeted therapies addressing specific neuropathic pain pathways and mechanisms, advancements in regenerative medicine techniques, digital therapeutic platforms integration for cognitive behavioral therapy, mindfulness-based interventions, and technological advancements in the early detection and monitoring of peripheral neuropathy diagnostic tools.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

What Are the Drivers Transforming the Peripheral Neuropathy Market?
The peripheral neuropathy market is likely to experience substantial growth due to increasing diabetes rates. Diabetes is defined as a long-term condition characterized by elevated blood sugar levels as a result of the body's inability to correctly use or generate insulin. The growing rate of diabetes can be attributed to multiple factors like rising obesity rates, sedentary lifestyles, and aging societies. Diabetes can induce peripheral neuropathy by damaging nerves over time because of persistently high blood sugar levels, resulting in symptoms such as discomfort, numbness, and a tingling sensation in the limbs. Effective blood sugar control is essential to halt or slow the advancement of this complication. For example, a report by The British Diabetic Association, a diabetes charity based in the UK, stated in April 2023 that 4.3 million individuals in the UK were diagnosed with diabetes. The registration data for 2021-22 witnessed an increase of 148,951 cases compared to 2020-21. Furthermore, over 2.4 million individuals in the UK are at a high risk for type 2 diabetes. As a result, the escalating rates of diabetes is a significant catalyst for the expansion of the peripheral neuropathy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16507&type=smp

What Long-Term Trends Will Define the Future of the Peripheral Neuropathy Market?
Leading businesses in the peripheral neuropathy market are concentrating their efforts on the creation of innovative solutions, such as point-of-care instruments, in order to enhance the detection and treatment of the disorder. Point-of-care quantitative screening tests for peripheral neuropathy serve as a fast diagnostic measure to identify peripheral nerve damage, especially in diabetic individuals. For example, NeuroMetrix Inc., a non-invasive medical device producer based in the United States, unveiled the DPNCheck 2.0 point-of-care device to identify peripheral neuropathy in January 2023. This apparatus utilizes nerve conduction technology to identify the widespread breakdown of peripheral nerves, potentially resulting in incapacitating conditions such as diabetic peripheral neuropathy (DPN). It provides speedy patient screening through the measurement of peripheral nerve function, asserting itself as a more precise and efficient instrument when compared to traditional testing methods like monofilament and tuning fork tests.

Which Segments in the Peripheral Neuropathy Market Offer the Most Profit Potential?
The peripheral neuropathy market covered in this report is segmented -

1) By Type: Chemotherapy-Induced, Diabetic, Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated, Idiopathic
2) By Diagnosis: Blood Test, Biopsy, Imaging, Other Diagnosis
3) By Treatment: Medications, Antidepressants, Anti-Seizure Medication, Pain Reliever, Topical Treatment, Therapies, Nerve Stimulation, Plasma Exchange, Physical Therapy, Other Treatments
4) By End-User: Hospitals, Clinics, Ambulatory Centers

Subsegments:
1) By Chemotherapy-Induced: Taxane-Induced Peripheral Neuropathy, Platinum-Based Drug-Induced Neuropathy, Other Chemotherapy-Induced Neuropathies
2) By Diabetic: Type 1 Diabetes-Induced Peripheral Neuropathy, Type 2 Diabetes-Induced Peripheral Neuropathy
3) By Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS) Associated: HIV-Associated Peripheral Neuropathy, AIDS-Related Peripheral Neuropathy
4) By Idiopathic: Acute Idiopathic Neuropathy, Chronic Idiopathic Neuropathy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16507&type=smp

Which Firms Dominate the Peripheral Neuropathy Market by Market Share and Revenue in 2025?
Major companies operating in the peripheral neuropathy market are Pfizer Inc., Merck and Co. Inc., Novartis AG, Bristol Myers Squibb Co, AstraZeneca Plc, Abbott Laboratories, Eli Lilly and Co., Asahi Kasei Corporation, Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Cadila Pharmaceuticals Ltd., Dr. Reddy's Laboratories, Cipla Ltd., Apotex Inc, Hikma Pharmaceuticals PLC, Lupin Limited, Grunenthal GmbH, ACI Limited, Lexicon Pharmaceuticals, Solasia Pharma KK, Helixmith Co. Ltd., PledPharma AB

Which Regions Offer the Highest Growth Potential in the Peripheral Neuropathy Market?
North America was the largest region in the peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16507

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.